TWQ-27263-78619
2 vaccinations
1 coded response
1 check-in
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 980 / WA
- Registered
- 2021-12-17
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-04-01
Dose 1 — Pfizer-BioNTech
-
2021-04-29
Dose 2 — Pfizer-BioNTech
-
2021-12-17
Registered in v-safe
-
2022-05-01
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I had covid 19MedDRA releases: 2024-11 · check-in free text available
-
2022-05-01
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-05-04
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | No |
| 2 | 2021-04-29 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 11 — 12 months, dose 2
Symptoms: I had covid 19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release